These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 16921538)
1. Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery. Bergen JM; von Recum HA; Goodman TT; Massey AP; Pun SH Macromol Biosci; 2006 Jul; 6(7):506-16. PubMed ID: 16921538 [TBL] [Abstract][Full Text] [Related]
2. A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 1. Synthesis and characterization. Popielarski SR; Pun SH; Davis ME Bioconjug Chem; 2005; 16(5):1063-70. PubMed ID: 16173781 [TBL] [Abstract][Full Text] [Related]
3. Ligand density effect on biorecognition by PEGylated gold nanoparticles: regulated interaction of RCA120 lectin with lactose installed to the distal end of tethered PEG strands on gold surface. Takae S; Akiyama Y; Otsuka H; Nakamura T; Nagasaki Y; Kataoka K Biomacromolecules; 2005; 6(2):818-24. PubMed ID: 15762646 [TBL] [Abstract][Full Text] [Related]
4. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Shenoy DB; Amiji MM Int J Pharm; 2005 Apr; 293(1-2):261-70. PubMed ID: 15778064 [TBL] [Abstract][Full Text] [Related]
5. Galactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes. Zhang XQ; Wang XL; Zhang PC; Liu ZL; Zhuo RX; Mao HQ; Leong KW J Control Release; 2005 Feb; 102(3):749-63. PubMed ID: 15681095 [TBL] [Abstract][Full Text] [Related]
6. A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 2. In vitro and in vivo uptake results. Popielarski SR; Hu-Lieskovan S; French SW; Triche TJ; Davis ME Bioconjug Chem; 2005; 16(5):1071-80. PubMed ID: 16173782 [TBL] [Abstract][Full Text] [Related]
7. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles. Bravo-Osuna I; Schmitz T; Bernkop-Schnürch A; Vauthier C; Ponchel G Int J Pharm; 2006 Jun; 316(1-2):170-5. PubMed ID: 16580797 [TBL] [Abstract][Full Text] [Related]
8. Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity. van den Berg JH; Oosterhuis K; Hennink WE; Storm G; van der Aa LJ; Engbersen JF; Haanen JB; Beijnen JH; Schumacher TN; Nuijen B J Control Release; 2010 Jan; 141(2):234-40. PubMed ID: 19751778 [TBL] [Abstract][Full Text] [Related]
9. A new generation of polymer nanoparticles for drug delivery. Chauvierre C; Vauthier C; Labarre D; Couvreur P; Marden MC; Leclerc L Cell Mol Biol (Noisy-le-grand); 2004 May; 50(3):233-9. PubMed ID: 15209344 [TBL] [Abstract][Full Text] [Related]
10. Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study. Kah JC; Wong KY; Neoh KG; Song JH; Fu JW; Mhaisalkar S; Olivo M; Sheppard CJ J Drug Target; 2009 Apr; 17(3):181-93. PubMed ID: 19016072 [TBL] [Abstract][Full Text] [Related]
11. The forthcoming applications of gold nanoparticles in drug and gene delivery systems. Pissuwan D; Niidome T; Cortie MB J Control Release; 2011 Jan; 149(1):65-71. PubMed ID: 20004222 [TBL] [Abstract][Full Text] [Related]
12. Stabilizing of plasmid DNA in vivo by PEG-modified cationic gold nanoparticles and the gene expression assisted with electrical pulses. Kawano T; Yamagata M; Takahashi H; Niidome Y; Yamada S; Katayama Y; Niidome T J Control Release; 2006 Apr; 111(3):382-9. PubMed ID: 16487614 [TBL] [Abstract][Full Text] [Related]
14. Amine-functionalized gold nanoparticles as non-cytotoxic and efficient intracellular siRNA delivery carriers. Lee SH; Bae KH; Kim SH; Lee KR; Park TG Int J Pharm; 2008 Nov; 364(1):94-101. PubMed ID: 18723087 [TBL] [Abstract][Full Text] [Related]
15. Application of NMR spectroscopy to the characterization of PEG-stabilized lipid nanoparticles. Garcia-Fuentes M; Torres D; Martín-Pastor M; Alonso MJ Langmuir; 2004 Sep; 20(20):8839-45. PubMed ID: 15379515 [TBL] [Abstract][Full Text] [Related]
16. Targeted Paclitaxel by conjugation to iron oxide and gold nanoparticles. Hwu JR; Lin YS; Josephrajan T; Hsu MH; Cheng FY; Yeh CS; Su WC; Shieh DB J Am Chem Soc; 2009 Jan; 131(1):66-8. PubMed ID: 19072111 [TBL] [Abstract][Full Text] [Related]
17. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration. Gao X; Tao W; Lu W; Zhang Q; Zhang Y; Jiang X; Fu S Biomaterials; 2006 Jun; 27(18):3482-90. PubMed ID: 16510178 [TBL] [Abstract][Full Text] [Related]
18. PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue. Eck W; Craig G; Sigdel A; Ritter G; Old LJ; Tang L; Brennan MF; Allen PJ; Mason MD ACS Nano; 2008 Nov; 2(11):2263-72. PubMed ID: 19206392 [TBL] [Abstract][Full Text] [Related]
19. A polycation scaffold presenting tunable "click" sites: conjugation to carbohydrate ligands and examination of hepatocyte-targeted pDNA delivery. Lee CC; Grandinetti G; McLendon PM; Reineke TM Macromol Biosci; 2010 Jun; 10(6):585-98. PubMed ID: 20480507 [TBL] [Abstract][Full Text] [Related]
20. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]